Abstract:The mechanism of neuronal loss in Alzheimer's disease (AD) remains unknown, although circumstantial evidence of apoptosis in postmortem brain tissues has supported the hypothesis that an apoptotic mechanism plays a role in the neurodegeneration in AD. Mutations in presenilins 1 and 2 (PS1/2) are responsible for the majority of familial AD. These proteins are localized predominantly in the endoplasmic reticulum (ER) and Golgi apparatus, and form heteromeric protein complexes to participate in several functions. Previous studies have shown that PS1/2 are involved in the regulation of apoptotic cell death, although the molecular basis is still unresolved. The aim of this study is to clarify the molecular basis by which PS1/2 regulate apoptosis. We also address a question how presenilin mutations modify the regulatory activity. We performed yeast 2–hybrid screen, co–immunoprecipitation assay, glycerol velocity gradient centrifugation and subcellular fractionation with iodixanol gradient, using HEK293 cells, PS1/2–knockout mouse fibroblasts and I213T–PS1–knockin mouse brains. PS1/2 interacted with FKBP38 that is an immunophilin family member residing in the mitochondrial membrane and inhibits apoptosis by targeting and anchoring anti–apoptotic Bcl–2 to the mitochondria. PS1/2 and FKBP38 formed macromolecular complexes together with Bcl–2. This complex formation promoted the degradation of FKBP38 and Bcl–2, and sequestered these proteins in the ER/Golgi compartments, thereby inhibiting FKBP38–mediated mitochondrial targeting of Bcl–2. Thus, full–length PS1/2 increased the susceptibility to apoptosis by antagonizing the anti–apoptotic function of FKBP38. In contrast, C–terminal fragments of caspase–processed PS1/2 redistributed Bcl–2 to the mitochondria by abrogating the activity of full–length PS1/2, resulting in a dominant–negative anti–apoptotic effect. In cultured cells and mutant PS1–knockin mouse brains, familial AD–linked PS1/2 mutants enhanced the pro–apoptotic activity by causing a more efficient reduction in mitochondrial Bcl–2 than wild–type PS1/2. We demonstrated that PS1/2 regulate the susceptibility to apoptosis by interacting with FKBP38. These results suggest a novel molecular mechanism for the regulation of mitochondria–mediated apoptosis by competition between PS1/2 and FKBP38 for subcellular targeting of Bcl–2. Furthermore, familial AD–linked mutations in PS1/2 could lower the threshold for activation of mitochondria–mediated apoptosis pathways in neurons of individuals with familial AD.

Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis

Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology

Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

Ferroptosis Signaling Pathways: Alzheimer's Disease

Increased Vulnerability to Ferroptosis in FUS-ALS

Interaction of Presenilins with FKBP38 Promotes Apoptosis by Reducing Mitochondrial Bcl-2.

Loss of Ferroportin Induces Memory Impairment by Promoting Ferroptosis in Alzheimer's Disease

Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy

P3-402: Pathogenic Mutations of Presenilins Enhance Pro-Apoptotic Activity by Reducing Mitochondrial Bcl-2

Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer’s Disease

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations

A familial Alzheimer's disease associated mutation in presenilin-1 mediates amyloid-beta independent cell specific neurodegeneration

NFE2L1-mediated proteasome function protects from ferroptosis

Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer's Disease

The E280A Presenilin 1 Alzheimer Mutation Produces Increased Aβ42 Deposition and Severe Cerebellar Pathology